Innovative surgery for treating complex carotid artery blockages
A New Surgical Method for Treating Tandem Carotid Lesions: Gao's Triple Eversion Carotid Endarterectomy
Second Affiliated Hospital, School of Medicine, Zhejiang University · NCT06722222
This study is testing a new type of surgery for people with complicated carotid artery blockages to see if it is safe and works better than older methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 11 (estimated) |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University (other) |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06722222 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates Gao's triple eversion carotid endarterectomy (GTE-CEA), a novel surgical technique designed to address tandem carotid lesions that traditional carotid endarterectomy cannot effectively treat. The study involves a retrospective review of patient charts from those who underwent GTE-CEA since September 2021, focusing on patients with significant carotid artery stenosis. The goal is to assess the safety and efficacy of this innovative approach in managing complex carotid artery conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with tandem carotid lesions and significant carotid artery stenosis, either symptomatic or asymptomatic.
Not a fit: Patients with asymptomatic carotid artery stenosis less than 50% or those who do not meet the diagnostic criteria for carotid artery stenosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this technique could provide a new treatment option for patients with complex carotid artery stenosis, potentially improving surgical outcomes.
How similar studies have performed: While traditional carotid endarterectomy has been widely studied, the specific approach of Gao's triple eversion CEA is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meet the diagnostic criteria for TCL stenosis. * Above 70% asymptomatic CCA and ICA stenosis or \> 50% symptomatic CAS confirmed by DSA or CTA before surgery Exclusion Criteria: * Did not meet the diagnostic criteria for CAS * Asymptomatic CAS \< 50% (as confirmed by DSA or CTA before surgery) * With stenosis at the opening of the CCA.
Where this trial is running
Hangzhou, Zhejiang
- the Second Affiliated Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang, China (RECRUITING)
Study contacts
- Study coordinator: Jinren Zhou, Dr.
- Email: 2324050@zju.edu.cn
- Phone: 15995090018
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Carotid Artery Stenosis, carotid artery stenosis, tandem carotid lesion